KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $908.0 million.

  • Cme's Profit After Tax fell 52.59% to $908.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 860.12%. This contributed to the annual value of $3.5 billion for FY2024, which is 928.65% up from last year.
  • Per Cme's latest filing, its Profit After Tax stood at $908.0 million for Q3 2025, which was down 52.59% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Profit After Tax registered a high of $1.0 billion during Q2 2025, and its lowest value of $510.6 million during Q2 2021.
  • For the 5-year period, Cme's Profit After Tax averaged around $787.9 million, with its median value being $814.6 million (2023).
  • Per our database at Business Quant, Cme's Profit After Tax surged by 12504.25% in 2021 and then crashed by 2664.87% in 2022.
  • Cme's Profit After Tax (Quarter) stood at $625.2 million in 2021, then rose by 2.03% to $637.9 million in 2022, then grew by 27.7% to $814.6 million in 2023, then increased by 7.37% to $874.6 million in 2024, then rose by 3.82% to $908.0 million in 2025.
  • Its last three reported values are $908.0 million in Q3 2025, $1.0 billion for Q2 2025, and $956.2 million during Q1 2025.